Pages that link to "Q98282795"
Jump to navigation
Jump to search
The following pages link to Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection (Q98282795):
Displaying 10 items.
- A prospective, randomized, open-label trial of early versus late favipiravir in hospitalized patients with COVID-19 (Q99863254) (← links)
- Favipiravir and the Need for Early Ambulatory Treatment of SARS-CoV2 Infection (COVID-19) (Q99616150) (← links)
- Re: 'effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients' by Fiolet et al (Q100295403) (← links)
- Rational for meta-analysis and randomized treatment: the COVID-19 example (Q100961209) (← links)
- Unproven Therapy Algorithms for Early SARS-CoV-2 Infection Are Dangerous (Q107652690) (← links)
- Concerning Pathophysiology and Justifying Clinical Trials (Q107652835) (← links)
- Clinical Omissions in COVID-19 (Q108064292) (← links)
- The Brazilian Scientific Denialism Through The American Journal of Medicine (Q124630021) (← links)
- The American Journal of Medicine Responds (Q124631063) (← links)
- Wikidata talk:WikiCite/Archive 6 (← links | edit)